| [1] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
|
| [2] |
Lim S, Rhim H, Lee MW, et al. New radiofrequency device to reduce bleeding after core needle biopsy: experimental study in a porcine liver model[J]. Korean J Radiol, 2017, 18(1):173-179.
|
| [3] |
Leuchte K, Staib E, Thelen M, et al. Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinoma[J]. Cancer Immunol Immunother, 2021, 70(4):893-907.
|
| [4] |
Yang G, Xiong Y, Sun J, et al. The efficacy of microwave ablation versus liver resection in the treatment of hepatocellular carcinoma and liver metastases: a systematic review and meta-analysis[J]. Int J Surg, 2020(77):85-93.
|
| [5] |
Ryu T, Takami Y, Wada Y, et al. Hepatic resection versus operative microwave ablation for single hepatocellular carcinoma ≤5 cm: a propensity score-matched analysis[J]. Surgery, 2019, 166(3):254-262.
|
| [6] |
周瑞, 李珊, 万文军, 等. 手术切除与局部热消融治疗小肝癌预后比较[J/OL]. 中华肝脏外科手术学电子杂志, 2021, 10(3):258-262.
|
| [7] |
Xie DY, Ren ZG, Zhou J, et al. 2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights[J]. Hepatobiliary Surg Nutr, 2020, 9(4):452-463.
|
| [8] |
Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma[J]. Hepatology, 2018, 67(1): 358-380.
|
| [9] |
Seki T, Wakabayashi M, Nakagawa T, et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma[J]. Cancer, 1994, 74(3):817-825.
|
| [10] |
An C, Cheng Z, Yu X, et al. Ultrasound-guided percutaneous microwave ablation of hepatocellular carcinoma in challenging locations: oncologic outcomes and advanced assistive technology[J]. Int J Hyperthermia, 2020, 37(1):89-100.
|
| [11] |
Meloni MF, Francica G, Chiang J, et al. Use of contrast-enhanced ultrasound in ablation therapy of HCC: planning, guiding, and assessing treatment response[J]. J Ultrasound Med, 2021, 40(5):879-894.
|
| [12] |
Wang Y, Zhang L, Li Y, et al. Computed tomography-guided percutaneous microwave ablation with artificial ascites for problematic hepatocellular tumors[J]. Int J Hyperthermia, 2020, 37(1):256-262.
|
| [13] |
陈嵩, 庄文权, 郭文波, 等. CT联合超声引导下经皮微波消融治疗尾状叶肝癌的可行性及短期疗效观察[J]. 影像诊断与介入放射学, 2018, 27(3):219-225.
|
| [14] |
Yang N, Gong J, Yao L, et al. Magnetic resonance imaging-guided microwave ablation of hepatic malignancies: feasibility, efficacy, safety, and follow-up[J]. J Cancer Res Ther, 2020, 16(5):1151-1156.
|
| [15] |
Winkelmann MT, Gohla G, Kübler J, et al. MR-guided high-power microwave ablation in hepatic malignancies: initial results in clinical routine[J]. Cardiovasc Intervent Radiol, 2020, 43(11):1631-1638.
|
| [16] |
Zhang K, Liu M, Xu Y, et al. Multiparametric magnetic resonance-guided and monitored microwave ablation in liver cancer[J]. J Cancer Res Ther, 2020, 16(7):1625-1633.
|
| [17] |
Li Z, Wang C, Si G, et al. Image-guided microwave ablation of hepatocellular carcinoma (≤5.0 cm): is MR guidance more effective than CT guidance?[J]. BMC Cancer, 2021, 21(1): 366.
|
| [18] |
Lu A, Woodrum DA, Felmlee JP, et al. Improved MR-thermometry during hepatic microwave ablation by correcting for intermittent electromagnetic interference artifacts[J]. Phys Med, 2020(71):100-107.
|
| [19] |
沈强, 王能, 张敬磊, 等. 超声引导下微波消融治疗肝细胞肝癌的短期预后及影响因素分析[J]. 第二军医大学学报, 2021, 42(6): 603-608.
|
| [20] |
高孟, 李开艳, 罗洪昌, 等. 原发性小肝癌超声引导下经皮微波消融与手术切除疗效的对比研究[J]. 中华超声影像学杂志, 2015, 24(1):35-39.
|
| [21] |
刘文斌, 马金良, 荚卫东, 等. 腹腔镜超声与开腹超声引导肝癌微波消融的对比分析[J]. 肝胆外科杂志, 2019, 27(4):249-253.
|
| [22] |
Santambrogio R, Barabino M, D'Alessandro V, et al.Laparoscopic thermoablation for hepatocellular carcinoma in patients with liver cirrhosis: an effective procedure for tricky tumors[J]. Med Oncol, 2020, 37(4):32.
|
| [23] |
2019年肝癌中西医临床协作专家委员会.原发性肝癌中西医结合介入诊疗专家共识(试行第一版)[J].临床肝胆病杂志, 2022, 38(1):70-77.
|
| [24] |
Li W, Ni CF. Current status of the combination therapy of transarterial chemoembolization and local ablation for hepatocellular carcinoma[J]. Abdom Radiol, 2019, 44(6):2268-2275.
|
| [25] |
冯含昕, 赵阳, 徐锋, 等. 微波消融技术在肝癌治疗的应用现状和展望[J/CD]. 中华普通外科学文献(电子版), 2020, 14(6):458-462.
|
| [26] |
Li X, Chen B, An C, et al. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: a propensity score matching study [J]. J Cancer Res Ther, 2020, 16(5):1027-1037.
|
| [27] |
孔文韬, 汤阳, 张小龙, 等. 靶向超声造影评价微波消融联合贝伐单克隆抗体对裸小鼠肝癌种植瘤的疗效[J]. 中华消化杂志, 2016, 36(12):845-848.
|
| [28] |
Dou C, Zhou Z, Xu Q, et al. Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca2+/PI3K/AKT pathway[J]. Oncogene, 2019, 38(8):1239-1255.
|
| [29] |
Jin M, Yu Q, Liu Y, et al. Safety and efficacy of physical thermal ablation combined sorafenib for hepatocellular carcinoma: a meta-analysis[J]. J Clin Transl Hepatol, 2021, 9(2):149-159.
|
| [30] |
Zhou Y, Yang Y, Zhou B, et al. Challenges facing percutaneous ablation in the treatment of hepatocellular carcinoma: extension of ablation criteria[J]. J Hepatocell Carcinoma, 2021(8):625-644.
|
| [31] |
Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update[J]. Radiology, 2014, 273(1):241-260.
|
| [32] |
Reimer RP, Hokamp NG, Niehoff J, et al. Value of spectral detector computed tomography for the early assessment of technique efficacy after microwave ablation of hepatocellular carcinoma[J]. PLoS One, 2021, 16(6):e0252678.
|
| [33] |
Swan RZ, Sindram D, Martinie JB, et al. Operative microwave ablation for hepatocellular carcinoma: complications, recurrence, and long-term outcomes[J]. J Gastrointest Surg, 2013, 17(4):719-729.
|